Clever people, those City and Wall St folks. The share price of drug giant GlaxoSmithKline (GSK) fell 4 per cent in just one day’s trading this week after the US drugs regulator, the Food and Drug Administration (FDA), issued a long-overdue warning...
DON'T GROW OLD: Or don't take the drugs
HRT diehards continue to effuse over the long-term benefits of HRT, but the latest evidence shows that long-term hormones offer a greater risk of dying early from cancer or stroke. As little as 10 years ago, it was considered heresy to criticise the...
Another study has found that short acting calcium antagonists used to prevent heart attacks are dangerous if given to patients with high blood pressure. The long acting kind did not have the same ...
Just 18 months after the UK’s Department of Health declared that the slimming drug Reductil (sibutramine) was safe, fresh evidence from the USA suggests that they may need to think again.
Yet another clinical trial of tamoxifen can’t decide if the drug is worth taking.
Originally hailed as a major contribution to breast cancer prevention, tamoxifen has had a bumpy ride
Anyone out there who still believes that the system of drug safety regulation works and that the folks in the regulatory agencies have our best interests at heart ought to read the story of Lotron ...
The Alzheimer’s drug Reminyl (galantamine hydrobromide) could prove fatal to patients with mild cognitive impairment (MCI), according to Ortho-McNeil Neurologics, the company that makes the drug. The warning was issued to healthcare professionals...
It’s been just a few short months since Avastin (bevacizumab) was being hailed as the great new breakthrough drug for cancer therapy. It is the first drug designed to stop angiogenesis, the development of new blood vessels to carry vital nutrients...
A recent report further cripples the last vestiges of support for hormone replacement therapy as a must-have treatment for menopause.
What Doctors Don't Tell You